These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21112394)

  • 21. Collagen and prostaglandin E₂ regulate aromatase expression through the PI3K/AKT/IKK and the MAP kinase pathways in adipose stromal cells.
    Tan T; Wang L; Wang B
    Mol Med Rep; 2015 Sep; 12(3):4766-4772. PubMed ID: 26059638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 90 inhibitors: new mode of therapy to overcome endocrine resistance.
    Wong C; Chen S
    Cancer Res; 2009 Nov; 69(22):8670-7. PubMed ID: 19861537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
    Richards JA; Petrel TA; Brueggemeier RW
    J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
    J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.
    Ye L; Gho WM; Chan FL; Chen S; Leung LK
    Int J Cancer; 2009 Mar; 124(5):1028-36. PubMed ID: 19065667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
    Chan HJ; Petrossian K; Chen S
    J Steroid Biochem Mol Biol; 2016 Jul; 161():73-83. PubMed ID: 26277097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
    Lu Y; Zi X; Zhao Y; Pollak M
    Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
    Wang Y; Lee KW; Chan FL; Chen S; Leung LK
    Toxicol Sci; 2006 Jul; 92(1):71-7. PubMed ID: 16611627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
    Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.
    Yue W; Wang JP; Conaway MR; Li Y; Santen RJ
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):265-74. PubMed ID: 14623520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
    Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
    Sengupta S; Schiff R; Katzenellenbogen BS
    Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.
    Masri S; Phung S; Wang X; Chen S
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):277-82. PubMed ID: 19897035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
    Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
    Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
    Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
    Wang J; Gildea JJ; Yue W
    Oncogene; 2013 Oct; 32(44):5233-40. PubMed ID: 23178495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line.
    Martin EC; Bratton MR; Zhu Y; Rhodes LV; Tilghman SL; Collins-Burow BM; Burow ME
    PLoS One; 2012; 7(11):e49067. PubMed ID: 23226206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation.
    Grube BJ; Eng ET; Kao YC; Kwon A; Chen S
    J Nutr; 2001 Dec; 131(12):3288-93. PubMed ID: 11739882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of growth factor signaling in genetically diverse breast cancer lines.
    Niepel M; Hafner M; Pace EA; Chung M; Chai DH; Zhou L; Muhlich JL; Schoeberl B; Sorger PK
    BMC Biol; 2014 Mar; 12():20. PubMed ID: 24655548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.